Found 17 matching trials
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
PHASE3This study is a Phase 3, multi-center, open-label trial to evaluate the lon...
Status
Enrolling By Invitation
Location
Clinical Research Site
Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol
PHASE3PARADIGM (Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Us...
Location
Clinical Research Site
Solriamfetol and CBT-I in Patients With Insomnia Disorder
PHASE4Medication is FDA approved. The objective of this project is to test the ef...
Location
University of Pennsylvania, Behavioral Sleep Medicine Program
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
PHASE3ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Di...
Location
Clinical Research Site
Solriamfetol in Binge Eating Disorder
PHASE4The goal of this project is to evaluate the efficacy and tolerability of th...
Location
Lindner Center of HOPE
A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
PHASE3This study is a Phase 3, multi-center, randomized, 6-week, double-blind, pl...
Location
Clinical Research Site
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
PHASE3This is a Phase 3, multi-center, open-label and randomized withdrawal study...
Status
Enrolling By Invitation
Location
Clinical Research Site
Evaluate Sunosiยฎ PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
PHASE1The purpose of study JZP110-401 is to evaluate solriamfetol pharmacokinetic...
Location
M3-Wake Research, Inc.
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
PHASE3CLARITY (Clinical Assessment of Response in the Treatment of Depression wit...
Location
Clinical Research Site
A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)
PHASE3FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solri...
Location
Clinical Research Site